Earlier, Pan et al. [33] showed that peptide prodrugs improved the efficacy of cytotoxic drugs; however, they were cleavable by peptidases, including CD10 present in the tumor environment, according to which blockade of CD10 increased the therapeutic index of such drugs. The gene discussed is MME; the disease is neoplasm.